» Articles » PMID: 15767529

Use of Clinical Prediction Rules in Detecting Osteoporosis in a Population-based Sample of Postmenopausal Women

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2005 Mar 16
PMID 15767529
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoporosis clinical prediction rules attempt to identify the postmenopausal women in whom, on the basis of individual risk factors, bone densitometry will detect low bone mass. We assessed and compared the diagnostic properties of the following 3 osteoporosis clinical prediction rules: the Simple Calculated Osteoporosis Risk Estimation, Osteoporosis Risk Assessment Instrument, and National Osteoporosis Foundation practice guidelines.

Methods: Secondary data analysis of an existing population-based sample of postmenopausal women 45 years or older (N = 202) in Rochester, Minn.

Results: Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, and positive (LR+) and negative (LR-) likelihood ratios were calculated using the World Health Organization diagnosis of osteoporosis as the reference standard. The Simple Calculated Osteoporosis Risk Estimation had a sensitivity of 100%, specificity of 29%, PPV of 27%, NPV of 100%, LR+ of 1.4, and LR- of 0. The Osteoporosis Risk Assessment Instrument had a sensitivity of 98%, specificity of 40%, PPV of 29%, NPV of 77%, LR+ of 1.4, and LR- of 0.4. The National Osteoporosis Foundation practice guidelines had a sensitivity of 100%, specificity of 10%, PPV of 27%, NPV of 100%, LR+ of 1.1, and LR- of 0. The Simple Calculated Osteoporosis Risk Estimation and Osteoporosis Risk Assessment Instrument were much more specific in postmenopausal women younger than 65 years compared with those 65 years or older.

Conclusions: Our results suggest that these clinical prediction rules do not perform well as a general screening method to identify postmenopausal women who are more likely to have osteoporosis; however, the Osteoporosis Risk Assessment Instrument and Simple Calculated Osteoporosis Risk Estimation may be useful in identifying some women who need not undergo testing, especially younger postmenopausal women.

Citing Articles

A Comparison of Radiographic Film Densitometry Using a New Computerized Tool with a Digital Densitometer.

Fakhar H, Razavi E, Soheilifar S, Kharazifard M J Dent (Tehran). 2017; 13(4):252-260.

PMID: 28127317 PMC: 5253218.


Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.

Crandall C Curr Osteoporos Rep. 2015; 13(5):287-301.

PMID: 26233285 DOI: 10.1007/s11914-015-0282-z.


Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density.

Nayak S, Edwards D, Saleh A, Greenspan S Osteoporos Int. 2015; 26(5):1543-54.

PMID: 25644147 PMC: 4401628. DOI: 10.1007/s00198-015-3025-1.


US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.

Bansal S, Pecina J, Merry S, Kennel K, Maxson J, Quigg S Osteoporos Int. 2015; 26(4):1429-33.

PMID: 25614141 DOI: 10.1007/s00198-015-3026-0.


The utility of clinical decision tools for diagnosing osteoporosis in postmenopausal women with rheumatoid arthritis.

Brand C, Lowe A, Hall S BMC Musculoskelet Disord. 2008; 9:13.

PMID: 18230132 PMC: 2270830. DOI: 10.1186/1471-2474-9-13.